Data / Drug companies / Aminoketone
Aminoketone drugs: 11 drugs from 74 companies in the FDA NDC directory
Aminoketone is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 348 products in this class from 74 companies, covering 11 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on September 30, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 74Companies
- 348Products
- 11Drugs by generic name
Drugs in the Aminoketone class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Bupropion hydrochloride | 326 | 67 |
| Bupropion | 5 | 3 |
| Bupropion hydrobromide | 6 | 2 |
| Bupropion hcl er (xl) | 2 | 2 |
| Bupropion hydrochloride (xl) | 2 | 1 |
| Dextromethorphan hydrobromide, bupropion hydrochloride | 2 | 1 |
| Bupropion hcl | 1 | 1 |
| Bupropion hcl er | 1 | 1 |
| Bupropion hcl er(sr) | 1 | 1 |
| Bupropion hydrochloride sr | 1 | 1 |
| Naltrexone hydrochloride and bupropion hydrochloride | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 27 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | April 25, 2024 |
| Bryant Ranch Prepack | 27 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | April 25, 2024 |
| Remedyrepack Inc. | 20 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | August 26, 2026 |
| Epic Pharma, LLC | 14 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | September 30, 2026 |
| Coupler LLC | 11 | tablet; tablet, extended release | Generic drugs (ANDA) | August 3, 2026 |
| Preferred Pharmaceuticals Inc. | 10 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | July 24, 2026 |
| Proficient Rx LP | 10 | tablet, film coated, extended release; tablet, extended release | Generic drugs (ANDA) | February 17, 2015 |
| Cipla USA Inc. | 9 | tablet, extended release; tablet | Generic drugs (ANDA) | October 25, 2023 |
| Dr. Reddy's Laboratories Inc. | 9 | tablet, film coated, extended release; tablet, extended release | Generic drugs (ANDA) | May 15, 2018 |
| NuCare Pharmaceuticals,Inc. | 9 | tablet, extended release; tablet, film coated | Generic drugs (ANDA) | April 30, 2023 |
| Aphena Pharma Solutions - Tennessee, LLC | 8 | tablet, film coated, extended release; tablet, film coated | Generic drugs (ANDA) | January 30, 2025 |
| Major Pharmaceuticals | 8 | tablet; tablet, film coated | Generic drugs (ANDA) | January 21, 2026 |
| Aurobindo Pharma Limited | 7 | tablet, film coated, extended release; tablet, film coated | Generic drugs (ANDA) | July 21, 2026 |
| Bryant Ranch Prepack | 7 | tablet, film coated, extended release; tablet | Generic drugs (ANDA) | April 20, 2018 |
| Direct_Rx | 7 | tablet, extended release; tablet, film coated | Generic drugs (ANDA) | April 30, 2026 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 6 | tablet, extended release; tablet, film coated | Generic drugs (ANDA) | April 25, 2024 |
| Proficient Rx LP | 6 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | March 25, 2019 |
| ScieGen Pharmaceuticals, Inc. | 6 | tablet, film coated, extended release | Generic drugs (ANDA) | May 1, 2019 |
| Actavis Pharma, Inc. | 5 | tablet, film coated, extended release | Generic drugs (ANDA) | July 2, 2009 |
| Bausch Health US LLC | 5 | tablet, extended release | New drug applications (NDA) | April 23, 2008 |
| Camber Pharmaceuticals, Inc. | 5 | tablet, extended release | Generic drugs (ANDA) | October 1, 2025 |
| Granules Pharmaceuticals Inc. | 5 | tablet, film coated, extended release; tablet, extended release | Generic drugs (ANDA) | March 31, 2025 |
| PD-Rx Pharmaceuticals, Inc. | 5 | tablet, extended release; tablet, film coated | Generic drugs (ANDA) | April 30, 2023 |
| Proficient Rx LP | 5 | tablet, extended release; tablet, film coated | Generic drugs (ANDA) | April 30, 2023 |
| Radha Pharmaceuticals, Inc. | 5 | tablet, film coated, extended release | Generic drugs (ANDA) | October 26, 2022 |
| Slate Run Pharmaceuticals, LLC | 5 | tablet, extended release | Generic drugs (ANDA) | November 2, 2020 |
| Advanced Rx of Tennessee, LLC | 4 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | August 29, 2025 |
| American Health Packaging | 4 | tablet, extended release; tablet, film coated | Generic drugs (ANDA) | January 15, 2024 |
| AvPAK | 4 | tablet, extended release; tablet, film coated | Generic drugs (ANDA) | March 5, 2025 |
| BluePoint Laboratories | 4 | tablet, film coated; tablet | Generic drugs (ANDA) | April 9, 2024 |
| Bryant Ranch Prepack | 4 | tablet, film coated, extended release | Generic drugs (ANDA) | April 20, 2018 |
| Chartwell RX, LLC | 4 | tablet; tablet, extended release | Generic drugs (ANDA) | August 21, 2017 |
| Northwind Health Company, LLC | 4 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | October 5, 2022 |
| PD-Rx Pharmaceuticals, Inc. | 4 | tablet; tablet, film coated, extended release | Generic drugs (ANDA) | August 19, 2016 |
| Cardinal Health 107, LLC | 3 | tablet, film coated; tablet, film coated, extended release | Generic drugs (ANDA) | June 9, 2025 |
| GlaxoSmithKline LLC | 3 | tablet, film coated | New drug applications (NDA) | June 25, 2002 |
| Macleods Pharmaceuticals Limited | 3 | tablet, extended release | Generic drugs (ANDA) | June 23, 2026 |
| Oceanside Pharmaceuticals | 3 | tablet, extended release | Authorized generics (NDA) | June 29, 2026 |
| Solco Healthcare US, LLC | 3 | tablet, film coated, extended release | Generic drugs (ANDA) | November 1, 2014 |
| Accord Healthcare Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | March 25, 2019 |
| Alembic Pharmaceuticals Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | January 10, 2024 |
| Alembic Pharmaceuticals Limited | 2 | tablet, film coated | Generic drugs (ANDA) | June 18, 2018 |
| American Health Packaging | 2 | tablet, film coated, extended release | Generic drugs (ANDA) | April 2, 2015 |
| Amici Pharma, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | May 21, 2026 |
| Amneal Pharmaceuticals of New York LLC | 2 | tablet, film coated, extended release | Generic drugs (ANDA) | May 1, 2009 |
| Apotex Corp. | 2 | tablet, film coated | Generic drugs (ANDA) | January 17, 2006 |
| Asclemed USA, Inc. | 2 | tablet, film coated, extended release; tablet, extended release | Generic drugs (ANDA) | February 17, 2015 |
| Axsome Therapeutics, Inc. | 2 | tablet, multilayer, extended release | New drug applications (NDA) | May 8, 2026 |
| Cadila Pharmaceuticals Limited | 2 | tablet, film coated | Generic drugs (ANDA) | January 16, 2020 |
| Exelan Pharmaceuticals Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | February 1, 2019 |
| Golden State Medical Supply, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | January 17, 2006 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 2 | tablet | Generic drugs (ANDA) | August 19, 2016 |
| Lannett Company, Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | January 8, 2018 |
| Lupin Pharmaceuticals, Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | June 14, 2017 |
| Modavar Pharmaceuticals LLC | 2 | tablet, film coated | Generic drugs (ANDA) | January 16, 2020 |
| Mullan Pharmaceutical Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | June 17, 2024 |
| Northwind Health Company, LLC | 2 | tablet, film coated, extended release | Generic drugs (ANDA) | January 12, 2026 |
| Oryza Pharmaceuticals Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | October 1, 2020 |
| Quallent Pharmaceuticals Health LLC | 2 | tablet, extended release | Generic drugs (ANDA) | July 7, 2023 |
| Rising Pharma Holdings, Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | August 1, 2022 |
| Upsher-Smith Laboratories, LLC | 2 | tablet, film coated, extended release | Authorized generics (NDA) | December 15, 2023 |
| Vitruvias Therapeutics | 2 | tablet, extended release | Generic drugs (ANDA) | April 10, 2023 |
| Zydus Lifesciences Limited | 2 | tablet, extended release | Generic drugs (ANDA) | August 2, 2018 |
| Zydus Pharmaceuticals USA Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | August 2, 2018 |
| Actavis Pharma, Inc. | 1 | tablet, extended release | Generic drugs (ANDA) | February 17, 2015 |
| Direct RX | 1 | tablet, extended release | Generic drugs (ANDA) | February 15, 2024 |
| Hawaii Repack, Inc. | 1 | tablet, extended release | Generic drugs (ANDA) | February 17, 2015 |
| Lifestar Pharma LLC | 1 | tablet, extended release | New drug applications (NDA) | May 1, 2026 |
| Nalpropion Pharmaceuticals LLC | 1 | tablet, extended release | New drug applications (NDA) | October 22, 2014 |
| QPharma, Inc. | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | November 1, 2014 |
| Quality Care Products, LLC | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | August 28, 2024 |
| St. Mary's Medical Park Pharmacy | 1 | tablet, film coated | Generic drugs (ANDA) | May 21, 2025 |
| Sun Pharmaceutical Industries, Inc. | 1 | tablet, extended release | Generic drugs (ANDA) | December 25, 2014 |
| Unit Dose Solutions, Inc. | 1 | tablet | Generic drugs (ANDA) | June 8, 2026 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, extended release | 160 | 46% |
| Tablet, film coated, extended release | 101 | 29% |
| Tablet, film coated | 56 | 16.1% |
| Tablet | 29 | 8.3% |
| Tablet, multilayer, extended release | 2 | 0.6% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.